Medtech manufacturers and users need to be ever alert to the risk of theft of…
Written by Dr Miri Halperin Wernli and Prof Boaz Ganor
First Published in: IN VIVO: The Business & Medicine Report | February 2015 |
Medtech manufacturers and users need to be ever alert to the risk of theft of intellectual property, regulatory violations, and loss of proprietary information assets. Security should be a top priority for executives thinking of entering the market with innovative medical devices, according to Miri Halperin Wernli, PhD, VP, deputy head global clinical development, global head business and science affairs, Actelion Pharmaceuticals Ltd., and Boaz Ganor, PhD, of the Tel Aviv-based International Institute for Counter-Terrorism (ICT), who addressed these issues at the ICT’s 14th International Conference on Counter-Terrorism in Herzliya, Israel last year.